Delivery Order 36C10X24D0028-36C10X25N0265
Award Date
9/30/25
Potential Completion Date
9/29/29
Potential Value
$6.6M
Federal Agency
VA Strategic Acquisition Center Frederick
Awardee
Fulgent Therapeutics LLC
Ultimate Awardee
Fulgent Genetics, Inc.
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21703, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $6,489,759.80 firm fixed price Indefinite Delivery/Indefinite Quantity (IDIQ) contract awarded by the Department of Veterans Affairs (VA) Strategic Acquisition Center to Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc., for germline genetic testing services. The contract has a 3-year term through September 2025 and is not set-aside. The contract will provide national access to specialized comprehensive reference laboratory testing services, including mandatory...
This is a $2,849,000.00 Firm Fixed Price Delivery Order contract awarded by the U.S. Department of Veterans Affairs (VA) Strategic Acquisition Center-Frederick to Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc. The contract provides for GERMLINE PGX MOLECULAR TESTING services with a period of performance through September 29, 2029. This award is part of a larger $99,032,828.20 multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract held by Fulgent Genetics with...
This is a federal contract award to Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc., by the Veterans Integrated Service Network 17 (VISN 17) of the U.S. Department of Veterans Affairs. The contract is for $1,010,000.00 and is for genetic testing services, with a period of performance through September 30, 2028. The contract is a definitive, firm-fixed-price contract and is not designated as a set-aside. Fulgent Therapeutics has secured multiple federal contract awards, primarily...
This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Fulgent Genetics, Inc., a for-profit genetic testing and diagnostics company. The contract, valued at $296,400.00, is for genetic testing services to be provided to the VA Portland Health Care System. The award does not utilize a set-aside designation, indicating Fulgent Genetics competed in an open federal procurement process. This contract...
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, for germline genetic testing services. The contract has a ceiling value of $95,817.89 and a period of performance through September 30, 2018. It was awarded as a total small business set-aside. Fulgent Diagnostics is a provider of genomic testing services and COVID-19 testing kits and services to various federal agencies, including the VA,...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price purchase order to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, for $201,500 to provide clinical genetic testing services for chronic kidney disease. The contract has a performance period through January 17, 2024. Fulgent Diagnostics is a division of Fulgent Genetics, Inc., which specializes in genetic and genomic testing services for the federal government, including the VA,...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, a subsidiary of Fulgent Genetics, Inc. The contract is for the delivery of laboratory testing kits, with a ceiling value of $889,097.43 and a period of performance through December 30, 2024. There was no set-aside designation used for this award. Fulgent Diagnostics is a provider of genomic testing services and COVID-19 testing kits...
The Department of Veterans Affairs Veterans Health Administration awarded Fulgent Therapeutics LLC a $3.2 million firm fixed price delivery order against its Medical Laboratory Testing and Analysis Services GSA Schedule contract. Fulgent Therapeutics, doing business as Fulgent Diagnostics and a division of Fulgent Genetics, will provide COVID-19 cost per test services to VHA's Veterans Integrated Service Network 21 through December 2020. The contract supports VHA's coronavirus disease testing...
The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price purchase order valued at $7,251 to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, a division of Fulgent Genetics, Inc. The contract is for anatomic pathology laboratory services to be performed at the Southern Arizona VA Healthcare System in Tucson, Arizona, over a one-year base period ending August 31, 2023. Services include pathology consultations, immunohistochemical staining,...
This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, for SARS-COV-2 genomic sequencing services. The firm fixed price contract has a potential value of $40,517,395.00 and a completion date of March 10, 2022. Fulgent Diagnostics is a division of Fulgent Genetics, Inc. and has provided genetic and genomic testing services to various federal agencies,...